Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

NCT00414609 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

820

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Aliskiren
DRUG: placebo

Sponsor

Novartis